Greencoat UK Wind - Appointment of a Non-Executive Director

9/10/2021 @ 6:00:00 AM

RNS Number : 3256L
Greencoat UK Wind PLC
10 September 2021

10 September 2021


(the "Company")

Appointment of a Non-Executive Director

The Company is pleased to announce that its Board of Directors has appointed Nick Winser as a non-executive director of the Company. Nick will also be a member of the Company's Audit, Management Engagement and Nominations Committees. His appointment will be effective from 1 January 2022.

Nick has a 30-year career in the energy sector which included CEO of National Grid across UK and Europe, President of the European Network of Transmission System Operators for Electricity and CIGRE UK Chair. Nick has been the chairman of Energy Systems Catapult since 2015 and was appointed chairman of the Advisory Board for the Energy Revolution ISCF programme in 2018 and served on the Advisory Panel for the Cost of Energy Review in 2017. He is also a member of the Net Zero Expert Group and a COP26 Advisory Group which advises the Secretary of State.

Shonaid Jemmett-Page, Chairman said:

"With Nick's extensive experience in energy markets and regulation we believe that he will make a valuable contribution to the Company."

No further disclosures are required for Nick Winser in respect of paragraphs 9.6.13 of the Financial Conduct Authority's Listing Rules. 


For further information:

Ocorian Administration (UK) Limited - Company Secretary        028 9693 0219      

Josh Finlay



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.